The combined efficacy of warming Yang therapy and Western medicine in the treatment of dilated cardiomyopathy with heart failure: A Meta-analysis
Journal Title: Drug Combination Therapy - Year 2020, Vol 2, Issue 3
Abstract
Background: To evaluate the clinical efficacy of oral administration of Chinese medicines with warming Yang effects and Western medicine in the treatment of heart failure caused by dilated cardiomyopathy. Methods: Seven databases including Chinese National Knowledge Infrastructure, Weipu database, Wanfang database, China Biomedical Literature Service System, Cochrane library, PubMed, and Embase were searched. The search date was from established to October 2019. Randomized clinical trials of dilated cardiomyopathy patients with heart failure under the combination treatment of Chinese medicines with warming Yang effects and Western medicine were included. We then assessed the methodological quality of included literatures, extracted valid data and conducted systematically evaluation according to the Cochrane systematic review method. Outcome index included clinical efficacy, left ventricular ejection fraction, and brain natriuretic peptide. Results: Meta-analysis results showed that the clinical effective rate was higher in the combination group than that in the control group (RR = 1.24, 95% CI (1.14, 1.34), P < 0.01). In addition, the combination group could improve left ventricular ejection fraction compared with the control group (Std. MD = 0.85, 95% CI (0.69, 1.01), P < 0.01). However, the meta-analysis of brain natriuretic peptide levels showed that the included literatures have higher heterogeneity and the meta-analysis results were unstable. So the results of brain natriuretic peptide were abandoned. Conclusion: Oral administration of Chinese medicines with warming Yang effects combined with Western medicine is better than Western medicine alone in improving clinical effect and left ventricular ejection fraction, but it is not clear whether brain natriuretic peptide can be improved. Because the quality of the included studies is not high and inconsistent outcome index, more standardized and rigorous randomized double-blind controlled trials are needed to validate and guide clinical use.
Authors and Affiliations
Zhe-Tao Zhang, Xiao Liu, Ze-Yuan Wei, Chao-Liang Tang
Keywords
Related Articles
- EP ID EP685187
- DOI 10.12032/DCT2020B024
- Views 182
- Downloads 0
Analysis on the compatibility rules and mechanism of formulae treatment for COVID-2019 based on the TCM inheritance assistance system and network pharmacology
Background : On December 8, 2019, Wuhan City, Hubei Province, a new type of coronavirus disease 2019 (COVID-2019) was firstly discovered, and COVID-2019 spread rapidly in China. The number of confirmed cases in various p...
The analgesic, anti-inflammatory, and anti-infection effects of Chai Ge fever relief oral liquid
Backgroud: To explore the analgesic, anti-inflammatory, and anti-infective effects of Chai Ge fever relief oral liquid and provide evidence for clinical application of Chai Ge fever relief oral liquid. Methods: In this s...
Study on the therapeutic effect of external application of ShouNian Powder combined with acupuncture at Zhitong acupoint on ICBN syndrome after breast cancer operation
Background: To explore the clinical effect of external application of ShouNian Powder combined with acupuncture at Zhitong acupoint in the treatment of intercostobrachial nerve syndrome (ICBNs) after breast cancer operat...
The combined efficacy of warming Yang therapy and Western medicine in the treatment of dilated cardiomyopathy with heart failure: A Meta-analysis
Background: To evaluate the clinical efficacy of oral administration of Chinese medicines with warming Yang effects and Western medicine in the treatment of heart failure caused by dilated cardiomyopathy. Methods: Seven...
Stability and compatibility of common traditional Chinese medicine injections matching with fructose injection
In recent years, China has attached great importance to the work of traditional Chinese medicine (TCM), more and more Chinese patent medicines are included in the national medical insurance catalogue, and the clinical ap...